Clinical Trial Detail

NCT ID NCT02713373
Title Cetuximab and Pembrolizumab in Treating Patients With Colorectal Cancer That is Metastatic or Cannot Be Removed by Surgery
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements yes
Sponsors Roswell Park Cancer Institute
Indications

colorectal cancer

Therapies

Cetuximab + Pembrolizumab

Age Groups: adult

Additional content available in CKB BOOST